Скачать презентацию Maternal Risk Factors Fetal Assessment High Risk Скачать презентацию Maternal Risk Factors Fetal Assessment High Risk

d67ec6bbea69bb7051c89da30ee1a614.ppt

  • Количество слайдов: 88

Maternal Risk Factors Fetal Assessment Maternal Risk Factors Fetal Assessment

High Risk Pregnancy n The life or health of the mother or fetus is High Risk Pregnancy n The life or health of the mother or fetus is jeopardized n Examples include: – GDM – Previous loss – AMA – HTN – Abnormalities with the neonate

Perinatal Mortality n Overall maternal deaths are small n Many deaths a preventable n Perinatal Mortality n Overall maternal deaths are small n Many deaths a preventable n Education and prenatal care very important

Antepartum Testing FKCs BID n UTZ n – – – – – FHR Gestation Antepartum Testing FKCs BID n UTZ n – – – – – FHR Gestation age Abnormalities IUGR Placental location and quality AFI Position BPP Doppler flow Fetal growth

Ultrasound n Can be done abdominally or transvaginally n 1 st trimester done to Ultrasound n Can be done abdominally or transvaginally n 1 st trimester done to detect viability, calculate EDC n 2 nd trimester done to detect anomalies, calculate EDC n 3 rd trimester done to do BPP, fetal growth and well-being, AFI

Doppler Flow Analysis via UTZ n Study blood blow in the fetus and placenta Doppler Flow Analysis via UTZ n Study blood blow in the fetus and placenta n Done on high risk mothers: – IUGR – HTN – DM – Multiple gestation

AFI n Polyhydramnios – too much amniotic fluid n Oligohydramnios – too little amniotic AFI n Polyhydramnios – too much amniotic fluid n Oligohydramnios – too little amniotic fluid

Biophysical Profile n Includes 5 components: – Fetal breathing movements – Gross body movements Biophysical Profile n Includes 5 components: – Fetal breathing movements – Gross body movements – Fetal tone – AFI – NST - reactive

Amniocentesis n Used with direct ultrasound n Less than 1% result in complications – Amniocentesis n Used with direct ultrasound n Less than 1% result in complications – Complications include: § Fetal death, miscarriage § Maternal hemorrhage § Infection to fetus § Preterm labor § Leakage of amniotic fluid

Meconium n Visual inspection of amniotic fluid n Meconium is defined as thin and Meconium n Visual inspection of amniotic fluid n Meconium is defined as thin and thick and particulate n Associated with fetal stress: hypoxia, umbilical cord compression

CVS n Done between 9 -12 weeks n Genetic studies n Removal of small CVS n Done between 9 -12 weeks n Genetic studies n Removal of small amount of tissue from the fetal portion of the placenta n Complications: vaginal spotting, miscarriage, ROM, chorioamnionitis n If done prior to 10 weeks, increased risk of limb anomalies

AFP n Genetic test n Done with mothers blood n 16 -20 weeks gestation AFP n Genetic test n Done with mothers blood n 16 -20 weeks gestation n Mandated by state of California

EFM n Third trimester goal is to continue to observe the fetus within the EFM n Third trimester goal is to continue to observe the fetus within the intrauterine environment n Goal: dx uteroplacental insufficiency n NST vs. CST

NST n 90% of gross fetal body movements are associated with accelerations of the NST n 90% of gross fetal body movements are associated with accelerations of the FHR n Can be performed outpatient n Not as sensitive n User friendly but must interpret strip n Fetus may be in a sleep state or affected by maternal medications, glucose etc.

NST n To be reactive must meet criteria n Must be at least 20 NST n To be reactive must meet criteria n Must be at least 20 minutes in length n Must have 2 or more accelerations that meet the ’ 15 X 15’ criteria n Must have a normal baseline n Must have LTV

NST n To stimulate a fetus that is not meeting criteria: – Change positions NST n To stimulate a fetus that is not meeting criteria: – Change positions of the mother – LS, RS – Increase fluids – Acoustic stimulator

CST n Done in the inpatient setting only! n Has contraindications n May be CST n Done in the inpatient setting only! n Has contraindications n May be expensive if meds/IV needed n Monitored for 10 minutes first n Then may use nipple stimulation or oxytocin stimulation n No late decelerations than negative CST

CST CST

Endocrine and Metabolic Disorders n #1 Diabetes Mellitus n Disorders of the thyroid n Endocrine and Metabolic Disorders n #1 Diabetes Mellitus n Disorders of the thyroid n Hyperemesis

Diabetes n Hyperglycemia n May be due to inadequate insulin action or due to Diabetes n Hyperglycemia n May be due to inadequate insulin action or due to impaired insulin secretion n Type 1 – insulin deficiency n Type 2 – insulin resistance n GDM – glucose intolerance during pregnancy

DM n 10 th week fetus produces it own insulin n Insulin does not DM n 10 th week fetus produces it own insulin n Insulin does not cross the placental barrier n Glucose levels in the fetus and directly proportional to the mother n 2 nd and 3 rd trimesters – decreased tolerance to glucose, increased insulin resistance, increased hepatic function of glucose

Diabetic Nephropathy n Increased risks for: – Preeclampsia – IUGR – PTL – Fetal Diabetic Nephropathy n Increased risks for: – Preeclampsia – IUGR – PTL – Fetal distress – IUFD – Neonatal death

DM n Poor glycemic control is associated with increased risks of miscarriage at time DM n Poor glycemic control is associated with increased risks of miscarriage at time of conception n Poor glycemic control in later part of pregnancy is assoc. with fetal macrosomia and polyhydramnios

Polyhydramnios n May compress on the vena cava and aorta causing hypotension, PROM, PP Polyhydramnios n May compress on the vena cava and aorta causing hypotension, PROM, PP hemorrhage, maternal dyspnea

Macrosomia n Disproportionate increase in shoulder and trunk size n 4000 -4500 gms or Macrosomia n Disproportionate increase in shoulder and trunk size n 4000 -4500 gms or greater n Fetus will have excess stores of glycogen n Increased risks of – Shoulder dystocia – C/S – Assisted deliveries

IUGR n Compromised uteroplacental insufficiency n 02 available to the fetus is decreased IUGR n Compromised uteroplacental insufficiency n 02 available to the fetus is decreased

RDS n Increased RDS due to high glucose levels n Delays pulmonary maturity RDS n Increased RDS due to high glucose levels n Delays pulmonary maturity

Neonatal Hypoglycemia n Usually 30 -60 minutes after birth n Due to high glucose Neonatal Hypoglycemia n Usually 30 -60 minutes after birth n Due to high glucose levels during pregnancy and rapid use of glucose after birth n Related to mothers level of glucose control

Labs with DM n HBA 1 c n 1 hour PP n FBS Labs with DM n HBA 1 c n 1 hour PP n FBS

Diet n Sweet success diet n Well balanced diet n 6 small meals / Diet n Sweet success diet n Well balanced diet n 6 small meals / day n Have snack at HS n Never skip meals n Avoid simple sugars

Insulin n Regular/Lispro and NPH n 2/3 dose in am and 1/3 dose in Insulin n Regular/Lispro and NPH n 2/3 dose in am and 1/3 dose in pm

Monitoring Glucose Levels n FBS n 1 hour PP n HS n 5 checks Monitoring Glucose Levels n FBS n 1 hour PP n HS n 5 checks / day

Fetal Surveillance n NSTs n At done around 26 weeks, weekly 32 weeks done Fetal Surveillance n NSTs n At done around 26 weeks, weekly 32 weeks done biweekly with NST/BPP

Infections and DM n Infections are increased: – Candidiasis – UTIs – PP infections Infections and DM n Infections are increased: – Candidiasis – UTIs – PP infections

DM n Increased risk of IUFD after 36 weeks n Increased congenital anomalies – DM n Increased risk of IUFD after 36 weeks n Increased congenital anomalies – Cardiac defects – CNS defects § Spina bifida § anencephaly – Skeletal defects

DM and labor n Continuous fetal monitoring n Blood glucose levels in tight control DM and labor n Continuous fetal monitoring n Blood glucose levels in tight control n Be prepared for CPD

GDM n Women with GDM at risk of developing DM later on in life GDM n Women with GDM at risk of developing DM later on in life n NSTs around 28 weeks

Hyperthyroidism n Typically caused by Grave’s disease n S/S: – Fatigue – Heat intolerance Hyperthyroidism n Typically caused by Grave’s disease n S/S: – Fatigue – Heat intolerance – Warm skin – Diaphoresis – Weight loss

n Should be treated in pregnancy n Tx with PTU n Beta blockers n n Should be treated in pregnancy n Tx with PTU n Beta blockers n May lead to thyroid storm if untreated

Hypothyroidism n Usually caused by Hashimoto’s n S/S: – Weight gain – Cold intolerance Hypothyroidism n Usually caused by Hashimoto’s n S/S: – Weight gain – Cold intolerance – Fatigue – Hair loss – Constipation – Dry skin

n Tx with thyroid hormones such as synthroid or levothyroxine n Maintain TSH wnl n Tx with thyroid hormones such as synthroid or levothyroxine n Maintain TSH wnl n Checked periodically throughout the pregnancy

Cardiovascular Disorders n The heart must compensate for the increased workload n If the Cardiovascular Disorders n The heart must compensate for the increased workload n If the cardiac changes are not well tolerated than cardiac failure can develop n 1% of pregnancies are complicated by heart disease

NY Heart Association Classes n Class III n Class IV NY Heart Association Classes n Class III n Class IV

n Cardiac output is increased n Peak of the increase 20 -24 weeks gestation n Cardiac output is increased n Peak of the increase 20 -24 weeks gestation n Cardiac problems should be managed with cardiologist n Mortality with pulmonary hypertension and pregnancy is more than 50% n Diet: low sodium

Nursing Care n Avoiding anemia n Avoid strenuous activity n Monitor for: cardiac failure Nursing Care n Avoiding anemia n Avoid strenuous activity n Monitor for: cardiac failure and pulmonary congestion

During Labor n Side lying position n Prophylactic antibiotic n Epidural n Attempt vaginal During Labor n Side lying position n Prophylactic antibiotic n Epidural n Attempt vaginal delivery n If anticoagulant therapy is needed: – Heparin – Lovenox

MVP n Common and usually benign n May experience syncope, palpitations and dyspnea n MVP n Common and usually benign n May experience syncope, palpitations and dyspnea n Prophylactic antibiotics given before invasive procedure or birth

Anemia n Most common iron deficiency n Hgb falls below 12 (most labs) n Anemia n Most common iron deficiency n Hgb falls below 12 (most labs) n Typically seen in the end of 2 nd trimester n Iron supplementation

Folic Acid Deficiency Anemia n Increases risk of NTD, cleft lip n Recommended dose Folic Acid Deficiency Anemia n Increases risk of NTD, cleft lip n Recommended dose 400 mcg/day n Supplemented in cereal and many other foods

Sickle Cell Anemia n Abnormal hemoglobin SS types in the blood n People have Sickle Cell Anemia n Abnormal hemoglobin SS types in the blood n People have recurrent attacks of fever and pain in the abdomen and extremities n Caused from tissue hypoxia, edema n African-Americans

Sickle Cell Trait n Typically asymptomatic n Sickling of the RBCs but with a Sickle Cell Trait n Typically asymptomatic n Sickling of the RBCs but with a normal RBC life span

Thalassemia n Common anemia n Insufficient amount of Hgb is produced to fill the Thalassemia n Common anemia n Insufficient amount of Hgb is produced to fill the RBCs n Mediterranean region n Genetic disorder n May be associated with LBW babies and increased fetal death

Asthma n Common with FH n 1 -4% of pregnant women have Asthma n Asthma n Common with FH n 1 -4% of pregnant women have Asthma n Possible adverse events associated with asthma: – LBW – Perinatal mortality – Preeclampsia – Complicated labor – Hyperemesis

Asthma Continued n Goal is to relieve the attack, prevent the asthma attack, and Asthma Continued n Goal is to relieve the attack, prevent the asthma attack, and maintain 02 n Should be managed with OB and ENT n May require tx: albuterol, steroids, O 2

Epilepsy n Seizure disorder n May result from developmental abnormalities or injury n 20% Epilepsy n Seizure disorder n May result from developmental abnormalities or injury n 20% have an increase in seizure activity during pregnancy n Risks: more seizures, risk of vaginal bleeding, abruptio placentae, fetus may experience seizures

Epilepsy Continued n Use of antiepeleptic meds during pregnancy has been linked to risks Epilepsy Continued n Use of antiepeleptic meds during pregnancy has been linked to risks for the fetus n Smallest therapeutic dose to be given n Daily folic acid supplementation n Managed with OB and neurologist

RA n Chronic arthritis n Pain upon movement and swelling in joint spaces n RA n Chronic arthritis n Pain upon movement and swelling in joint spaces n More often in women n 2/3 of women with RA find the severity of symptoms decrease during pregnancy n Typically give baby ASA

SLE n Inflammatory disease, autoimmune antibody production n Advised to wait until in remission SLE n Inflammatory disease, autoimmune antibody production n Advised to wait until in remission for 6 months to become pregnant n 15 -60% of women will develop exacerbation of SLE during pregnancy or postpartum n Tx: ASA and steroids

Cholelithiasis n More often in women n Pregnancy makes women more vulnerable n Surgery Cholelithiasis n More often in women n Pregnancy makes women more vulnerable n Surgery often delayed until after delivery

Appendicitis n Dx may take more time to find n Sxs: abdominal pain, nausea, Appendicitis n Dx may take more time to find n Sxs: abdominal pain, nausea, vomiting, loss of appetite n Increases incidence of PTL or SAB

Maternal Infections Maternal Infections

TORCH n Toxoplasmosis – protozoan infection, neonatal effects – jaundice, hydrocephalus, microcephaly n Other- TORCH n Toxoplasmosis – protozoan infection, neonatal effects – jaundice, hydrocephalus, microcephaly n Other- Heb A or B, Group B, Varicella, HIV n Rubella (German measles) – if contracted in 1 st Trimester fetus may have congenital deformities

TORCH n CMV- transmitted person to person, may cause CNS damage to fetus n TORCH n CMV- transmitted person to person, may cause CNS damage to fetus n Herpes Simplex (HSV 2) – if initial infection occurs in pregnancy, higher incidence of perinatal loss. Fetus may pick up virus if present in the vagina during labor

Mental Health Disorders Mental Health Disorders

Anxiety Disorders n Most common mental disorders n Include: phobias, panic disorders, OCD, PTSD Anxiety Disorders n Most common mental disorders n Include: phobias, panic disorders, OCD, PTSD n Tx: relaxation techniques, breathing exercises, imagery

Depression in Pregnancy n 6% of women develop depression for the 1 st time Depression in Pregnancy n 6% of women develop depression for the 1 st time during pregnancy n Tx: counseling and tx with SSRIs n Wellbutrin only med named as Category B n Many women opt to DC meds during pregnancy

Substance Abuse in Pregnancy Substance Abuse in Pregnancy

Substance Abuse n Damaging effects well documented in research to fetus n Any use Substance Abuse n Damaging effects well documented in research to fetus n Any use of ETOH or illicit drugs during pregnancy is considered abuse n 31% of women had used one or more substances during pregnancy (as compared to 62% during prepregnancy)

Smoking n Risks of any amount of smoking include: – SAB – SGA – Smoking n Risks of any amount of smoking include: – SAB – SGA – Bleeding – IUFD – Prematurity – SIDS

Alcohol n Many women reluctant to tell health care provider n Risks: – LBW Alcohol n Many women reluctant to tell health care provider n Risks: – LBW – Mental retardation – Learning and physical deficits – With FAS – severe facial deformities

Alcohol during Pregnancy n Risks to mother: – HTN – Anemia – Nutritional deficits Alcohol during Pregnancy n Risks to mother: – HTN – Anemia – Nutritional deficits – Pancreatitis – Cirrhosis – Alcoholic hepatitis

Marijuana n Crosses the placenta and causes increased carbon monoxide levels in mother’s blood Marijuana n Crosses the placenta and causes increased carbon monoxide levels in mother’s blood n May cause fetal abnormalities

Cocaine n In the US, 10 -15% of all pregnant women use cocaine n Cocaine n In the US, 10 -15% of all pregnant women use cocaine n Problems associated with use: polydrug use, poor health, poor nutrition, STIs, infections, HIV n Poverty big issue

Cocaine in Pregnancy n Maternal effects: – – – – – Cardiovascular stress Tachycardia Cocaine in Pregnancy n Maternal effects: – – – – – Cardiovascular stress Tachycardia HTN Dysrhythmias MI Liver damage Sz Pulmonary disease Death n Fetal Complications: – – Abruptio placentae PTL Precipitous labor Risks for abdominal pregnancy – Fetal complications after delivery

Opiates in Pregnancy n Drugs include: heroin, Demerol, morphine, codeine, methadone n Methadone is Opiates in Pregnancy n Drugs include: heroin, Demerol, morphine, codeine, methadone n Methadone is used to treat addiction to other opiates n Possible effects on pregnancy and heroin use are: Preeclampsia, PROM, infections, PTL n Tx: Methadone and psychotherapy n Goal: prevent withdrawal symptoms

Methamphetamine n CNS stimulant n Most common use n the 18 -30 yr old Methamphetamine n CNS stimulant n Most common use n the 18 -30 yr old range n Neonatal complications include: – IUGR – PRL/PTB

Postpartum Psychologic Complications Postpartum Psychologic Complications

Baby Blues n Usually within 4 weeks of childbirth n Many experience this Baby Blues n Usually within 4 weeks of childbirth n Many experience this

PPD n Intense sadness, crying all the time, mood swings, fears, anger, anxiety, irritability PPD n Intense sadness, crying all the time, mood swings, fears, anger, anxiety, irritability n Incidence of PPD at 8 weeks – 12% and 8% at 12 weeks n Many women feel guilty n May need tx but usually resolves on own

Postpartum Psychosis n Delusions, hurting self or the infant, emotional lability, insomnia, suspiciousness, confusion, Postpartum Psychosis n Delusions, hurting self or the infant, emotional lability, insomnia, suspiciousness, confusion, obsessive concerns regarding the baby n 1 -2/1000 births n 35 -60% recurrence with each subsequent birth n Usually symptoms appear within 8 weeks of birth

Medical Management n Supportive family n Intense psychotherapy n Emergency n Tx: SSRIs n Medical Management n Supportive family n Intense psychotherapy n Emergency n Tx: SSRIs n SSRIs contraindicated while breastfeeding

n 1. A client asks the nurse to again explain the purpose of the n 1. A client asks the nurse to again explain the purpose of the amniocentesis test. The nurse responds that one purpose of this test is to indicate the: – A. – B. – C. – D. – E. Accurate age of the fetus Presence of certain congenital anomalies Biparietal diameter of the skull Hormone content of the amniotic fluid Mainly the presence of Down’s syndrome

n 2. The nurse explains to a new mother that the condition of SGA n 2. The nurse explains to a new mother that the condition of SGA is caused by: – A. – B. – C. – D. Placental insufficiency Maternal obesity Primipara Genetic predisposition

n 3. A pregnant client with diabetes is controlled by insulin. When she asks n 3. A pregnant client with diabetes is controlled by insulin. When she asks the nurse what will happen to her insulin requirements during pregnancy, the correct response is: – A. “Because your case is so mild, you are likely not to need much insulin during your pregnancy” – B. “It’s likely that as the pregnancy progresses you will need increased insulin” – C. “Every case is individual so there is really no way to know” – D. “If you follow the diet closely and don’t gain too much weight, your insulin needs should stay the same”

n 4. The nurse in the newborn nursery understands that assessing a newborn with n 4. The nurse in the newborn nursery understands that assessing a newborn with a diabetic mother, initially the insulin level would be: – A. – B. – C. – D. Higher than in normal infants Lower than in normal infants The same as in normal infants Varied from baby to baby

n 5. A client is admitted to L&D, at 38 weeks gestation. She is n 5. A client is admitted to L&D, at 38 weeks gestation. She is there for evaluation because she is experiencing polyhydramnios. The nurse understands that this diagnosis means that: – A. There is the normal amount of amniotic fluid, thinner in volume – B. A less-than-normal amount of amniotic fluid is present – C. An excessive amount of amniotic fluid is present – D. A leak is causing the fluid to accumulate outside the amniotic sac